Related Experiment Video
Updated: Aug 17, 2026

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
Prostaglandin E1 inhibits collagenase gene expression in rabbit synoviocytes and human fibroblasts
R Salvatori1, P T Guidon, B E Rapuano
1Department of Medicine, Cornell University Medical College, New York, New York.
Abstract:
Cartilage breakdown, as seen in inflammatory and degenerative joint diseases, can be mediated by proteolytic enzymes, such as the metalloproteinase collagenase, the only enzyme able to digest collagen at neutral pH. In vitro collagenase gene expression can be stimulated by the phorbol ester tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate. We have investigated the effect of prostaglandin E1 (PGE1) on 12-O-tetradecanoyl-phorbol-13-acetate-stimulated collagenase mRNA levels in the rabbit synoviocyte cell line HIG-82. PGE1, but not PGE2 or PGF2 alpha, was able to selectively reduce collagenase mRNA levels in a dose-dependent fashion. PGE1 markedly increased intracellular levels of cAMP, while PGE2 and PGF2 alpha had little or no effect on cAMP production in the HIG-82 synoviocytes. Agents known to increase intracellular cAMP levels, such as the adenyl cyclase activator forskolin and the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX), mimicked the effect of PGE1, on collagenase mRNA levels. PGE1, forskolin, and IBMX also decreased collagenase mRNA levels in human skin fibroblasts, demonstrating that this observation was not unique to the HIG-82 cell line. Transient transfection experiments carried out in HIG-82 cells using a 1.2-kilobase portion of the 5'-flanking region of the human collagenase gene linked to the reporter gene luciferase demonstrated that PGE1, forskolin, and IBMX exert their inhibitory effect on the promoter region of the collagenase gene.
Insights
Prostaglandin E1 (PGE1) reduces collagenase mRNA levels, an enzyme linked to cartilage breakdown. This effect is mediated by increased intracellular cAMP levels, offering potential therapeutic insights for joint diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Cartilage breakdown in joint diseases involves proteolytic enzymes like collagenase.
- Collagenase gene expression is stimulated by 12-O-tetradecanoyl-phorbol-13-acetate (TPA).
Purpose of the Study:
- To investigate the effect of prostaglandin E1 (PGE1) on TPA-stimulated collagenase mRNA levels.
- To explore the role of intracellular cyclic AMP (cAMP) in this regulation.
Main Methods:
- Utilized the rabbit synoviocyte cell line HIG-82 and human skin fibroblasts.
- Measured collagenase mRNA levels following treatment with prostaglandins, forskolin, and IBMX.
- Performed transient transfection assays with a collagenase gene promoter-luciferase construct.
Main Results:
- PGE1 selectively reduced collagenase mRNA levels in a dose-dependent manner.
- PGE1 increased intracellular cAMP levels, an effect mimicked by forskolin and IBMX.
- PGE1, forskolin, and IBMX inhibited collagenase gene promoter activity.
Conclusions:
- PGE1, via increased cAMP, inhibits collagenase gene expression at the promoter level.
- This mechanism is conserved across different cell types, including synoviocytes and fibroblasts.
- Findings suggest potential therapeutic strategies for managing cartilage-degrading enzymes in joint diseases.

